FOLR1 and neoplasm: A multi-tumor study of 46 patients with cancer, of whom six had OvC, used the ApoStream® system (Precision for MedicineTM, Houston, TX, USA) for CTC enrichment followed by immunostainings including a FRα antibody and laser capture cytometry [86].